Abeona Therapeutics Inc vs Otis Worldwide Corp — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Otis Worldwide Corp trades at $73.25 (market cap $27.80B). The key difference: Otis Worldwide Corp is far larger — about 66× Abeona Therapeutics Inc's market cap, and Otis Worldwide Corp pays a 2.41% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | OTIS | |
|---|---|---|
Market Cap | $421.19M | $27.80B |
Sector | Health | Industrials |
52-Week High | $7.45 | $93.62 |
52-Week Low | $4.17 | $69.34 |
Enterprise Value | $276.10M | $35.84B |
Dividend Yield | — | 2.41% |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →